Bcal Diagnostics Ltd - Asset Resilience Ratio

Latest as of June 2023: 0.00%

Bcal Diagnostics Ltd (BDX) has an Asset Resilience Ratio of 0.00% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Bcal Diagnostics Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets

AU$0.00

≈ $0.00 USD Cash + Short-term Investments

Total Assets

AU$8.37 Million

≈ $5.92 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2022)

This chart shows how Bcal Diagnostics Ltd's Asset Resilience Ratio has changed over time. See Bcal Diagnostics Ltd net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Bcal Diagnostics Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BDX market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Bcal Diagnostics Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Bcal Diagnostics Ltd Industry Peers by Asset Resilience Ratio

Compare Bcal Diagnostics Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Eurofins-Cerep SA PA:ALECR	Diagnostics & Research	6.56%
Inoviq Ltd AU:IIQ	Diagnostics & Research	56.29%
Imagion Biosystems Ltd AU:IBX	Diagnostics & Research	150.16%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%
Cryosite Ltd AU:CTE	Diagnostics & Research	20.55%

Annual Asset Resilience Ratio for Bcal Diagnostics Ltd (2021–2022)

The table below shows the annual Asset Resilience Ratio data for Bcal Diagnostics Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	0.00%	AU$0.00 ≈ $0.00	AU$8.37 Million ≈ $5.92 Million	--
2021-12-31	37.77%	AU$4.00 Million ≈ $2.83 Million	AU$10.59 Million ≈ $7.49 Million	--

pp = percentage points

About Bcal Diagnostics Ltd

AU:BDX Australia Diagnostics & Research

Market Cap

$21.65 Million

AU$30.60 Million AUD

Market Cap Rank

#24798 Global

#1065 in Australia

Share Price

AU$0.08

Change (1 day)

+0.00%

52-Week Range

AU$0.05 - AU$0.14

All Time High

AU$0.25